Blue Star Limited — ≥1% Shareholders
Every non-promoter shareholder owning 1% or more of Blue Star Limited, parsed from the latest quarterly Shareholding Pattern filing. Curated holders link to a tracked profile; mystery holders are flagged.
1 curated
17 mystery
Quarter: Mar 2026
Institutional intelligence for Blue Star Limited
Cross-view mutual fund activity and super-investor shareholding · Mar 2026 SHP.
Tracked super investors holding ≥1%
| Holder | Type | % of company | Shares | Value (₹ Cr) |
|---|---|---|---|---|
| Vistra ITCL (India) Limited as a Trustee of Ashok M Advani Family Private Trust | dii | 11.63% | 2,39,11,202 | ₹3.85k Cr |
| Vistra ITCL (India) Limited as a Trustee of SMA Family Private Trust | dii | 7.57% | 1,55,69,860 | ₹2.51k Cr |
| Kotak Midcap Fund | dii | 4.47% | 92,01,145 | ₹1.48k Cr |
| Axis Mutual Fund Trustee Limited A/C Axis Mutual Fund A/C Axis Small Cap Fund | dii | 3.56% | 73,11,505 | ₹1.18k Cr |
| Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund | dii | 2.88% | 59,24,098 | ₹954.2 Cr |
| ICICI Prudential Multicap Fund | dii | 2.31% | 47,57,022 | ₹766.2 Cr |
| Vistra ITCL (India) Limited as a Trustee of NSA Family Trust | dii | 2.24% | 46,00,000 | ₹740.9 Cr |
| Vistra ITCL (India) Limited as a Trustee of SNA Family Trust | dii | 2.24% | 46,00,000 | ₹740.9 Cr |
| Rohina Lulla | individual | 2.12% | 43,49,260 | ₹700.5 Cr |
| Anissa Khanna | individual | 2.07% | 42,65,646 | ₹687.1 Cr |
| SBI Life Insurance Co. Ltd | dii | 1.94% | 39,81,782 | ₹641.3 Cr |
| SBI Multicap Fund | dii | 1.68% | 34,49,782 | ₹555.7 Cr |
| LIC | dii | 1.40% | 28,75,029 | ₹463.1 Cr |
| Fidelity Funds - India Focus Fund | fii | 1.22% | 25,07,317 | ₹403.9 Cr |
| Suneel Mohan Advani | individual | 1.19% | 24,54,992 | ₹395.4 Cr |
| Nargis Suneel Advani | individual | 1.11% | 22,73,872 | ₹366.3 Cr |
| Vir S Advani | individual | 1.08% | 22,30,731 | ₹359.3 Cr |
| Sunaina Murthy | individual | 1.04% | 21,45,050 | ₹345.5 Cr |
Shareholding data sourced from NSE/BSE regulatory filings. Not investment advice. See our disclaimer and methodology.